Average Co-Inventor Count = 4.95
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sanofi (9 from 1,454 patents)
2. Sanofi-a Ventis Deutschland Gmbh (7 from 1,829 patents)
3. Aventis Pharma Deutschland, Gmbh (2 from 330 patents)
18 patents:
1. 12275733 - Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders
2. 11827633 - Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders
3. 11130755 - Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders
4. 9675606 - 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
5. 9440941 - Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
6. 9126972 - 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
7. 9067918 - Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [ (S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl ]-amide
8. 8912224 - Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
9. 8809358 - Use of IκB-kinase inhibitors in pain therapy
10. 8778955 - Indole derivatives or benzimidazole derivatives for modulating IkB kinase
11. 8153637 - Phenyl-alkyl piperazines having TNF-modulating activity, preparation method, and therapeutic use thereof
12. 7462638 - Use of IκB-kinase inhibitors in pain therapy
13. 7348336 - Substituted β-carbolines
14. 7342029 - Substituted indoles
15. 7285560 - Indole derivatives or benzimidazole derivatives for modulating IκB kinase